Two organ-specific scoring frameworks
A fictional pathology team reviews a gastric biopsy for a predictive membrane biomarker. A trainee applies a breast scoring shortcut and assumes that every positive pattern must show complete circumferential membrane staining with the same percentage rule. The gastric material instead contains a small coherent group of tumor cells with strong lateral and basolateral staining. The responsible pathologist asks for the actual organ- and specimen-specific framework and appropriate controls before assigning the score. The case does not supply a reason to ignore a validated negative result, and it does not make staining alone a complete systemic-treatment order. The task is to recognize why a copied scoring rule can be inappropriate.
1. What is the methodological error?
Read the worked answer
An organ-specific biomarker framework cannot automatically be replaced with a breast shortcut. Gastric biopsy criteria can recognize different membrane patterns and sampling conditions.
2. What must accompany the interpretation?
Read the worked answer
Use the validated assay, appropriate controls and actual organ and specimen criteria, then communicate the result within the full clinical assessment.